{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05019",
      "entity_text" : "IGF-1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:9911830",
      "entity_text" : "Tivozanib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The paracrine activities of VECs in the 6% BMSC-CM group were also inhibited by Tivozanib, with a decreased production of BMP-2 and IGF-1 (XREF_FIG E, F).",
  "reading_complete" : "2020-08-04T14:25:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:24:52Z",
  "trigger" : "production",
  "evidence" : [ "Tivozanib, with a decreased production of BMP-2 and IGF-1" ],
  "pmc_id" : "6031349",
  "score" : 0
}